Implantable defibrillator with countershock synchronized to P-wave

• US 6,256,534 B1
• Filed: 08/11/1998
• Issued: 07/03/2001
• Est. Priority Date: 08/11/1998
• Status: Expired due to Term

• Current Assignee: Ela Medical S.A. (LivaNova Plc)
• Original Assignee: Angeion Corporation (Niterra Co., Ltd.)
• Inventors: Dahl, Roger
• Primary Examiner(s): Schaetzle, Kennedy
• Application Number:
  US09/132,225
• Time in Patent Office: 1,057 Days
• Field of Search: 607/5, 607/4, 600/518
• US Class Current: 607/5
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Abstract

An implantable defibrillator for treating cardiac dysrhythmias in a human patient in which the delivery of electrical defibrillation countershocks to a plurality of implanted electrodes is synchronized to predetermined aspect of an atrial portion of the cardiac signals sensed by the device. The defibrillator includes a sealed housing structure constructed of a biocompatible material containing a battery source of electrical energy and a capacitor system to store electrical energy provided by the battery source to generate high voltage electrical countershocks. A control system within the implantable defibrillator includes sensing circuitry that senses cardiac signals representative of a heart rate and detection circuitry that evaluates the cardiac signals to detect a ventricular fibrillation. The control system includes circuitry that operates to control the storing and discharge of electric energy in the capacity system through the plurality of implanted electrodes such that delivery of the electrical energy is synchronized to a predetermined aspect of an atrial portion of the cardiac signals that is a predetermined delay after the occurrence of a P-wave.

Claims

1. An implantable defibrillator for treating cardiac dysrhythmias in a human patient by delivering electrical countershocks to a plurality of implanted electrodes, the implantable defibrillator comprising:

a sealed housing structure constructed of a biocompatible material;

a battery source of electrical energy contained in the housing;

a capacitor system operably connected to the battery source to store electrical energy provided by the battery source to generate high voltage electrical countershocks;

a control system operably connected to the battery source and the capacitor system, including

sensing circuitry that senses cardiac signals representative of a heart rate;

detection circuitry operably connected to the sensing circuitry that evaluates the cardiac signals to detect a ventricular fibrillation; and

control circuitry operably connected to the detection circuitry and the sensing circuitry that controls the storing and discharge of electric energy in the capacitor system through the plurality of implanted electrodes such that delivery of the electrical energy is synchronized to a predetermined aspect of an atrial portion of the cardiac signals that is a predetermined delay after the occurrence of a P-wave.

2. The implantable defibrillator of claim 1 wherein the predetermined delay is based on a measured delay between at least one P-wave and one R-wave occurring prior to detection of the ventricular fibrillation.

3. The implantable defibrillator of claim 2 wherein the measured delay is an aspect of an A-V delay calculated by the implantable defibrillator for purposes of dual chamber pacing.

4. The implantable defibrillator of claim 1 wherein the sensing circuitry is connected to a first set of implanted electrodes for sensing the atrial portion of the cardiac signals and to a second set of implanted electrodes for sensing a ventricular portion of the cardiac signals.

5. A method of operating an implantable defibrillator for treating cardiac dysrhythmias in a human patient, the implantable defibrillator including a sealed housing structure constructed of a biocompatible material containing a battery source of electrical energy, a high voltage capacitor system and a control system which cooperate to deliver electrical countershocks to a plurality of implanted electrodes, the method comprising:

sensing cardiac signals representative of a heart rate;

using the control system to evaluate the cardiac signals to detect a ventricular fibrillation; and

delivering an electrical countershock through the implanted electrodes in response to detection of the ventricular fibrillation such that delivery of the electrical energy is synchronized to a predetermined aspect of an atrial portion of the cardiac signals that is a predetermined delay after the occurrence of a P-wave.

6. The method of claim 5 further comprising the step of measuring a delay between at least one P-wave and one R-wave occurring prior to detection of the ventricular fibrillation as the predetermined delay.

7. The method of claim 5 further comprising the step of calculating an A-V delay for purposes of dual chamber pacing and utilizing some aspect of the A-V delay as the predetermined delay.

8. The method of claim 5 wherein the step of sensing the cardiac signals is accomplished by utilizing a first set of implanted electrodes for sensing the atrial portion of the cardiac signals and by utilizing a second set of implanted electrodes for sensing a ventricular portion of the cardiac signals.